Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 36 (1), 118-37

The Nootropic Concept and Dyslexia

Affiliations

The Nootropic Concept and Dyslexia

C R Wilsher. Ann Dyslexia.

Abstract

A review is presented of controlled studies using intensive teaching intervention to improve dyslexics' reading ability. The results of eight controlled studies reveal only one showing the superiority of teaching. Taking this as a background, the work on Nootropics is reviewed. Both animal and clinical work with Piracetam (the first of the Nootropics) seems to indicate that this medication lacks significant or serious side effects and appears to promote memory and learning. Many double-blind studies of Piracetam have now been conducted on dyslexic children. These studies suggest that Piracetam improves the reading ability of dyslexics. In addition electrophysiological studies support the notion that Piracetam may be "left hemisphere active." Such encouraging trends will doubtless lead to further research in this interesting area.

Similar articles

  • Interaction Between Psychological and Pharmacological Treatment in Cognitive Impairment
    W Deberdt. Life Sci 55 (25-26), 2057-66. PMID 7997065. - Clinical Trial
    In contrast to other kinds of psychotropic drugs, nootropics or cognition enhancing drugs may be indicated, not for the direct treatment of the pathology itself, but for …
  • The Effects of Piracetam in Children With Dyslexia
    M Di Ianni et al. J Clin Psychopharmacol 5 (5), 272-8. PMID 3900148. - Clinical Trial
    Following previous research which suggests that piracetam improves performance on tasks associated with the left hemisphere, a 12-week, double-blind, placebo-controlled s …
  • Piracetam and Dyslexia: Effects on Reading Tests
    CR Wilsher et al. J Clin Psychopharmacol 7 (4), 230-7. PMID 3305591. - Clinical Trial
    Previous research has suggested that dyslexics treated with piracetam have shown improvements in reading skills, verbal memory and verbal conceptualizing ability, feature …
  • Effects of Piracetam on Developmental Dyslexia
    CR Wilsher. Int J Psychophysiol 4 (1), 29-39. PMID 3522508. - Review
    A new class of drugs (nootropics) are viewed from the perspective of their neuropsychological effect upon developmental dyslexia. Evidence from both the preclinical and c …
  • The Magnocellular Theory of Developmental Dyslexia
    J Stein. Dyslexia 7 (1), 12-36. PMID 11305228. - Review
    Low literacy is termed 'developmental dyslexia' when reading is significantly behind that expected from the intelligence quotient (IQ) in the presence of other symptoms-- …
See all similar articles

References

    1. J Am Acad Child Psychiatry. 1984 Nov;23(6):695-9 - PubMed
    1. Physiologie. 1977 Jul-Sep;14(3):165-72 - PubMed
    1. J Clin Psychopharmacol. 1985 Oct;5(5):272-8 - PubMed
    1. Psychopharmacologia. 1974 Mar 21;36(1):59-66 - PubMed
    1. Eur J Pharmacol. 1971 Nov-Dec;16(3):283-97 - PubMed
Feedback